Description |
aryl hydrocarbon receptor |
nuclear receptor coactivator 2 |
Image |
|
|
GO Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
- Diethylstilbestrol
- Estradiol
- Genistein
- Methyltrienolone
- 17-METHYL-17-ALPHA-DIHYDROEQUILENIN
- 4-(2-amino-1-methyl-1H-imidazo[4,5-b]pyridin-6-yl)phenol
- N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1-HYDROXY-1-(TRIFLUOROMETHYL)ETHYL]PHENYL}BENZENESULFONAMIDE
- 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-8-METHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
- 4-[(1S,2S,5S,9R)-5-(HYDROXYMETHYL)-8,9-DIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
- 4-[(1S,2S,5S)-5-(HYDROXYMETHYL)-6,8,9-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
- (9ALPHA,13BETA,17BETA)-2-[(1Z)-BUT-1-EN-1-YL]ESTRA-1,3,5(10)-TRIENE-3,17-DIOL
- (9BETA,11ALPHA,13ALPHA,14BETA,17ALPHA)-11-(METHOXYMETHYL)ESTRA-1(10),2,4-TRIENE-3,17-DIOL
- 3-CHLORO-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL
- 3-ETHYL-2-(4-HYDROXYPHENYL)-2H-INDAZOL-5-OL
- 2-chloro-5-nitro-N-phenylbenzamide
- dimethyl (1R,4S)-5,6-bis(4-hydroxyphenyl)-7-oxabicyclo[2.2.1]hepta-2,5-diene-2,3-dicarboxylate
- 4-[1-allyl-7-(trifluoromethyl)-1H-indazol-3-yl]benzene-1,3-diol
- 4-(6-HYDROXY-1H-INDAZOL-3-YL)BENZENE-1,3-DIOL
- (2E,4E)-11-METHOXY-3,7,11-TRIMETHYLDODECA-2,4-DIENOIC ACID
- DIETHYL (1R,2S,3R,4S)-5,6-BIS(4-HYDROXYPHENYL)-7-OXABICYCLO[2.2.1]HEPT-5-ENE-2,3-DICARBOXYLATE
- 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine
- 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID
- 4-[(1S,2R,5S)-4,4,8-TRIMETHYL-3-OXABICYCLO[3.3.1]NON-7-EN-2-YL]PHENOL
- tributylstannanyl
- RALOXIFENE CORE
|
Diseases |
|
|
GWAS |
- Alanine aminotransferase (ALT) levels after remission induction therapy in actute lymphoblastic leukemia (ALL) ( 28090653)
- Bitter beverage consumption ( 31046077)
- Bitter non-alcoholic beverage consumption ( 31046077)
- Blood metabolite levels ( 24816252)
- Caffeine consumption ( 21490707)
- Caffeine metabolism (plasma 1,3,7-trimethylxanthine (caffeine) level) ( 27702941)
- Caffeine metabolism (plasma 1,7-dimethylxanthine (paraxanthine) to 1,3,7-trimethylxanthine (caffeine) ratio) ( 27702941)
- Coffee consumption ( 31345160 21357676 29367735 31046077 25288136)
- Coffee consumption (cups per day) ( 25288136)
- Cutaneous squamous cell carcinoma ( 27424798)
- Estimated glomerular filtration rate ( 31152163)
- Inflammatory bowel disease ( 26192919)
- Lung cancer in ever smokers ( 28604730)
- Metabolic traits ( 21886157)
- Microalbuminuria ( 31511532)
- Plasma kynurenine levels in major depressive disorder ( 29317604)
- Rosacea symptom severity ( 29771307)
- Severe influenza A (H1N1) infection ( 26379185)
- Sweet beverage consumption ( 31046077)
- Tea consumption ( 31046077)
- Ulcerative colitis ( 26192919)
- Urinary albumin excretion ( 30220432)
- Urinary albumin excretion (no hypertensive medication) ( 30220432)
- Urinary albumin-to-creatinine ratio ( 31630189 30910378 31511532)
- Urinary potassium excretion ( 31409800)
- Urinary sodium excretion ( 31409800)
|
- Cardiac Troponin-T levels ( 23247143)
- HDL cholesterol ( 30275531)
- HDL cholesterol levels ( 28334899)
- Intelligence (MTAG) ( 29326435)
- Metabolite levels ( 23823483)
- Metabolite levels (HVA-5-HIAA Factor score) ( 23319000)
- Multiple sclerosis ( 24076602)
- Non-small cell lung cancer ( 23144319)
- QT interval ( 24952745)
- Serum alkaline phosphatase levels ( 29403010)
- Spherical equivalent or myopia (age of diagnosis) ( 29808027)
- Subclinical trait of interstitial lung disease (basilar peel-core ratio of high attentuation areas on CT scan) ( 28521775)
|
Interacting Genes |
35 interacting genes:
AIP
AR
ARNT
ARNT2
ARNTL
BRCA1
CCNT1
CUL4B
DAP3
EP300
ESR1
GTF2F1
GTF2F2
HSP90AA1
IVNS1ABP
NCOA1
NCOA2
NCOA7
NCOR2
NEDD8
NR2F1
NRIP1
PTGES3
RB1
RELA
SMARCA4
SP1
STUB1
TAF4
TAF6
TAF7
TAF9
TBL3
TBP
XPO1
|
63 interacting genes:
ACTN2
AHR
ANKRD11
AR
ARNT
BRCA1
CARM1
CCND3
CCNT1
CDK4
CREBBP
CTNNB1
DDX17
DDX5
DLX2
DLX5
EID1
EP300
ESR1
ESR2
ESRRB
ETV1
FOS
GMEB1
H3-4
H4-16
HIF1A
HNF4A
JUN
KIF5A
KIF5B
KIF5C
MAGEA11
MEF2C
NKX2-1
NR1I2
NR2F1
NR3C1
NR4A1
OPN1LW
PIAS3
PML
PPARA
PPARD
PPARG
PPFIA1
PPFIA4
PRMT1
PSMB9
RARA
RORA
RXRA
SLC30A9
SMARCE1
SRCAP
STAT6
SUMO1
TAF9
THRB
TP53
TXNRD2
VDR
YWHAH
|
Entrez ID |
196 |
10499 |
HPRD ID |
02596 |
09066 |
Ensembl ID |
ENSG00000106546
|
ENSG00000140396
|
Uniprot IDs |
A0A024R9Z8
P35869
|
B4DPW8
Q15596
|
PDB IDs |
5NJ8
|
1GWQ
1GWR
1M2Z
1MV9
1MVC
1MZN
1P93
1T63
1T65
1UHL
1YOK
1ZDT
1ZDU
1ZKY
2AO6
2B1V
2B1Z
2B23
2FAI
2G44
2G5O
2LDC
2P15
2P1T
2P1U
2P1V
2Q7J
2Q7L
2YJD
2ZXZ
2ZY0
3A9E
3CLD
3DZU
3DZY
3E00
3E7C
3E94
3ERD
3FUG
3GN8
3K22
3K23
3KWY
3KYT
3L0E
3L0J
3L0L
3O1D
3O1E
3OAP
3OZJ
3PCU
3PLZ
3Q95
3R5M
3UP0
3UP3
4CSJ
4DOS
4E2J
4FHH
4FHI
4IA1
4IA2
4IA3
4IA7
4IQR
4IU7
4IUI
4IV2
4IV4
4IVW
4IVY
4IW6
4IW8
4IWC
4IWF
4K4J
4K6I
4M8E
4M8H
4NIE
4NQA
4OC7
4P6W
4P6X
4PLD
4PLE
4POH
4POJ
4PP3
4PP5
4PP6
4PPP
4PPS
4PXM
4Q0A
4Q13
4QE6
4QE8
4RFW
4RMC
4RMD
4RME
4RUO
4UDC
4UDD
4WG0
4ZN7
4ZN9
4ZNH
4ZNS
4ZNT
4ZNU
4ZNV
4ZNW
4ZO1
4ZSH
5APH
5APJ
5DI7
5DID
5DIE
5DIG
5DK9
5DKB
5DKE
5DKG
5DKS
5DL4
5DLR
5DMC
5DMF
5DP0
5DRJ
5DRM
5DTV
5DU5
5DUE
5DUG
5DUH
5DVS
5DVV
5DWE
5DWG
5DWI
5DWJ
5DX3
5DXB
5DXE
5DXG
5DXK
5DXM
5DXP
5DXQ
5DXR
5DY8
5DYB
5DYD
5DZ0
5DZ1
5DZ3
5DZH
5DZI
5E0W
5E0X
5E14
5E15
5E19
5E1C
5EC9
5EGV
5EHJ
5EI1
5EIT
5G3J
5G42
5G43
5G44
5G45
5G46
5G5W
5H1E
5HYR
5I4V
5IAW
5ICK
5KCC
5KCD
5KCE
5KCF
5KCT
5KCU
5KCW
5KD9
5KR9
5KRA
5KRC
5KRF
5KRH
5KRI
5KRJ
5KRK
5KRL
5KRM
5KRO
5L11
5LGA
5LYQ
5MK4
5NFP
5NFT
5NI5
5NI7
5NI8
5NIB
5Q17
5SYZ
5T1Z
5TLD
5TLF
5TLG
5TLL
5TLM
5TLO
5TLP
5TLT
5TLU
5TLV
5TLX
5TLY
5TM1
5TM2
5TM3
5TM4
5TM5
5TM6
5TM7
5TM8
5TM9
5TML
5TMM
5TMO
5TMQ
5TMR
5TMS
5TMT
5TMU
5TMV
5TMW
5TMZ
5TN1
5TN3
5TN4
5TN5
5TN6
5TN7
5TN8
5U2D
5UAN
5VB3
5VB5
5VB6
5VB7
5VQK
5VQL
5WGQ
5WZX
5XPL
5Y1J
5Y49
5YP5
5YXB
5YXD
5YXJ
5YXL
5Z12
6CZN
6D0F
6EL6
6EL7
6EL9
6ESN
6KNU
6KNV
6KNW
6OQX
6OQY
6OR1
6R7A
6R7J
6R7K
6SJM
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
|
|
Tagcloud (Difference) ? |
|
|
Tagcloud (Intersection) ? |
|